Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The role of TSH in the human immune system
2008-001827-76Phase 2Active
- Sponsor
- Erasmus MC
- Start
- Jun 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, single-arm trial of thyrotropin alfa in Primary T-cell immunodeficiency (T-CID), human immunodeficiency virus infection (HIV), immunocompromise and 1 more, sponsored by Erasmus MC. Primary endpoint: Change in thymic output and peripheral T-cell subpopulations. Started Jun 2009; status: active.
02
Drugs
thyrotropin alfa
03
Conditions
Primary T-cell immunodeficiency (T-CID)human immunodeficiency virus infection (HIV)immunocompromiseT-lymphocyte deficiency
Beyond the preview
Go deeper on 2008-001827-76.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001827-76.